Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial

BACKGROUND: Androgen deprivation therapy (ADT) combined with docetaxel chemotherapy is the standard treatment for metastatic castration-resistant prostate cancer (mCRPC) patients. However, mCRPC patients are mainly frail elderly men, constantly accompanied by comorbidities and showing poor tolerance...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiangwei, Chen, Hong, Xu, Duanya, Chen, Xianju, Li, Yamei, Tian, Jun, Wang, Dongwen, Pang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848813/
https://www.ncbi.nlm.nih.gov/pubmed/35172779
http://dx.doi.org/10.1186/s12885-022-09276-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848813/
https://www.ncbi.nlm.nih.gov/pubmed/35172779
http://dx.doi.org/10.1186/s12885-022-09276-y

Ejemplares similares